Gene · 6421
NIH grants1,450
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 1,450
Download this page as JSON| Grant | Title | SFPQ papers | Newest fiscal year |
|---|---|---|---|
| P01HL028481 | Molecular Genetic Approaches in Atherosclerosis Research | 1 | 2019 |
| P50AG005133 | Alzheimer's Disease Research Center | 1 | 2019 |
| P50NS038377 | Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) | 1 | 2019 |
| R00CA197762 | Investigating the role of the small GTPase RIT1 in lung adenocarcinoma | 1 | 2019 |
| R00HG008399 | Discovering disease-causal variants by linking genetic and epigenetic variation | 1 | 2019 |
| R01AG050471 | RNA binding proteins as novel targets in Alzheimer's disease | 1 | 2019 |
| R01AI044924 | IFN-Gamma Gene Regulation in T Cells and NK Cells | 1 | 2019 |
| R01AI110985 | Regulation of Hematopoiesis by Ribosomal Protein Paralogs | 1 | 2019 |
| R01AI118852 | Topological Mechanisms of DNA Break Repair in Lymphocytes | 1 | 2019 |
| R01CA036401 | Pharmacogenomics of Childhood Leukemia ALL | 1 | 2019 |
| R01CA066980 | Biological Activity of HPV E7 in Human Epithelial Cells | 1 | 2019 |
| R01CA072851 | Familial and Early Onset Colorectal Cancer | 1 | 2019 |
| R01CA183764 | The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle | 1 | 2019 |
| R01CA184165 | Personalized Therapy of Hormone Refractory Breast Cancer | 1 | 2019 |
| R01CA184792 | Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer | 1 | 2019 |
| R01CA188571 | DYRK1A signaling in control of cell growth, proliferation and DNA damage repair | 1 | 2019 |
| R01CA194518 | Image-guided EMT inhibition for treating metastatic breast cancer | 1 | 2019 |
| R01CA196270 | Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer | 1 | 2019 |
| R01DK058702 | Nonintegrating Lentiviral Vectors Towards Clinical Trials | 1 | 2019 |
| R01DK103854 | U2AF1 mutations in myelodysplastic syndromes: from mechanism to therapy | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6421/grants?page=36